Members |
targetComponentId |
dotiepinhydroklorid 25 mg/5 ml, sockerfritt elixir |
Dosulepin 5 mg/mL oral solution |
dotiepinhydroklorid 75 mg/5 ml, oralt elixir |
Dosulepin 15 mg/mL oral solution |
dotiepinhydroklorid 75 mg/5 ml, sockerfritt elixir |
Dosulepin 15 mg/mL oral solution |
Double - DT - vaccination |
Preschool administration of diphtheria and tetanus vaccine |
Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
dubbel stjälkad lambå |
Reconstruction using bipedicled flap |
Downs inkontinensutrustning |
Incontinence appliance (physical object) |
Doxazosin mesylate 8mg tablet |
Doxazosin (as doxazosin mesilate) 8 mg oral tablet |
doxepinhydroklorid 10 mg/ml, oral lösning |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Doxepin metabolite |
Product containing doxepin (medicinal product) |
doxorubicinhydroklorid 10 mg, injektionsvätska, lösning, flaska |
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
doxorubicinhydroklorid 20 mg, injektionsvätska, lösning, flaska |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Doxorubicin liposomal 20mg/10ml injection |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
doxycyklin 100 mg, dispergerbar tablett |
Doxycycline 100 mg orodispersible tablet |
doxycyklin 40 mg, kapsel med modifierad frisättning |
Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
doxycyklin 75 mg, munsönderfallande tablett |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
doxycyklinkalcium 50 mg/5 ml, sirap |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
doxycyklinhyklat 10 %, subgingivalt system för läkemedelstillförsel |
Product containing only doxycycline in oromucosal dose form (medicinal product form) |
Doxycycline hyclate 200mg injection (pdr for recon) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
doxycyklinhyklat 200 mg, pulver till injektionsvätska, flaska |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
doxycyklinmonohydrat 25 mg/5 ml, suspension |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
Drain insertion - action |
Insertion - action (qualifier value) |
funktionell filtrationsblåsa |
Functional filtering bleb (finding) |
Drainage of cyst NEC |
Drainage procedure |
Drainage of organ NOC |
Drainage procedure |
Drainage of organ NOC NOS |
Drainage procedure |
Drechslera longirostrata |
Exserohilum longirostratum |
Dressing - action |
Application - action |
torkad faktor IX-fraktion, upphettad, 600 IE, pulver och vätska till injektionslösning, flaska |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
torkad faktor IX-fraktion, upphettad, 600 IE, pulver till injektionsvätska, lösning, flaska |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Drilling of organ NOC |
Drilling |
Drimaren briljantgult |
Textile colours and finishes patch test substance |
drop-attacker hos medelålders kvinna |
Drop attack |
drostanolonpropionatallergi |
Allergy to drostanolone (finding) |
drotrecogin alfa (aktiverat) 5 mg, pulver till infusionsvätska, lösning, flaska |
Drotrecogin alfa 5 mg powder for solution for injection vial |
drotrecogin alfa 20 mg, pulver till infusionsväska, lösning, flaska |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Drug |
Pharmaceutical / biologic product (product) |
Drug aerosol, 0,01% |
Drug aerosol |
Drug aerosol, 0,04% |
Drug aerosol |
Drug aerosol, 0,5% |
Drug aerosol |
Drug cream, 0,01% |
Cream |
Drug cream, 0,02% |
Cream |
Drug cream, 0,025% |
Cream |
Drug cream, 0,05% |
Cream |
Drug cream, 0,1% |
Cream |
Drug cream, 0,25% |
Cream |
Drug cream, 0,5% |
Cream |
Drug cream, 1% |
Cream |
Drug cream, 2,5% |
Cream |
substansberoende |
Substance dependence (disorder) |
Drug dependence - unspecified whether during pregnancy or the puerperium |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence NOS |
Substance dependence (disorder) |
Drug dependence NOS |
Substance dependence (disorder) |
Drug dependence during childbirth, puerperium (& pregnancy) |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
substansberoende under graviditet, förlossning och puerperium |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
Drug dependence during pregnancy, childbirth or the puerperium NOS |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
substansberoende vid förlossning |
Substance dependence in childbirth |
substansberoende hos moder som komplicerar graviditet, förlossning och/eller puerperium |
Substance dependence in mother complicating pregnancy, childbirth and/or puerperium (disorder) |
substansberoende i remission |
Substance dependence in remission |
kontinuerligt läkemedelsberoende |
Substance dependence, continuous |
substansberoende, episodiskt |
Substance dependence, episodic (disorder) |
Drug gel, 0,05% |
Gel |
Drug gel, 0,1% |
Gel |
Drug gel, 0,25% |
Gel |
biverkning av läkemedelsgrupper och medel som främst verkar på huden |
Adverse reaction to drug |
biverkning av läkemedelsgrupper som främst påverkar det autonoma nervsystemet |
Adverse reaction to drug |
biverkning av läkemedelsgrupper som främst påverkar hjärt-kärlsystemet |
Adverse reaction to drug |
biverkning av läkemedelsgrupper som främst påverkar det centrala nervsystemet |
Adverse reaction to drug |
biverkning av läkemedelsgrupper som främst påverkar mag-tarmsystemet |
Adverse reaction to drug |
biverkning av läkemedelsgrupper som främst påverkar det muskuloskeletala systemet |
Adverse reaction to drug |
biverkning av läkemedelsgrupper som främst påverkar andningssystemet |
Adverse reaction to drug |
Drug groups primarily affecting the autonomic nervous system |
Product containing autonomic agent (product) |
Drug induced rash (& ingestion dermatitis) |
Dermatitis caused by substance taken via oral route (disorder) |
halt av läkemedel eller drog i urinen över terapeutiskt intervall |
Urine substance level above reference range (finding) |
Drug ointment, 0,025% |
Ointment |
Drug ointment, 0,05% |
Ointment |
Drug ointment, 0,1% |
Ointment |
Drug ointment, 0,2% |
Ointment |
Drug ointment, 0,25% |
Ointment |
Drug ointment, 1% |
Ointment |
Drug ointment, 2,5% |
Ointment |
Drug reaction - CNS drug |
Adverse reaction to drug |
Drug reaction - CNS drug |
Adverse reaction to drug |
Drug reaction - CNS drug NOS |
Adverse reaction to drug |
Drug reaction - CNS drug NOS |
Adverse reaction to drug |
läkemedelsspecifikt allergenextrakt |
Pharmaceutical / biologic product (product) |
substansabstinens |
Substance withdrawal |
krampanfall vid drogabstinens |
Seizure co-occurrent and due to substance withdrawal |
Drug withdrawal syndrome |
Substance withdrawal |
Drug withdrawal syndrome |
Substance withdrawal |
Drug, medicament or biological substance |
Drug or medicament (substance) |
drog, läkemedel eller biologisk substans i urinen över referensintervallet |
Urine substance level above reference range (finding) |
substansutlöst impotens |
Erectile dysfunction caused by drug |
läkemedelsutlöst nefrogen diabetes insipidus |
Acquired nephrogenic diabetes insipidus |
drog- eller läkemedelsrelaterad sjukdom |
Disease |
Drugs in urine abnormal [D] |
Substance in urine detected by screening method (finding) |
läkemedel för behandling av hyperurikemi |
Uricosuric agent |
läkemedel för behandling av ämnesomsättningsstörningar |
Medicinal product categorised by therapeutic role |
Drusen |
Hyaline body |
toxisk effekt av innehåll i torrbatteri |
Toxic effect of sulfuric acid |
duktal ektasi |
Dilatation |